TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/13/2024
Back to search
Official data from USPTO
VERAXA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
VERAXA
ST13
US500000090784943Class
1, 5, 9, 10, 42, 44
Filing
90784943
Registration
7282793
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
11/13/2024
Trademark type
Word
Nice classes
1, 5, 9, 10, 42, 44
Filing date
06/21/2021
Registration date
01/23/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/23/2024
Last transaction
11/13/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
27
Owner location
HEIDELBERG, DE
Examiner
TARABAN, LAURA KRISTEN
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
VERAXA BIOTECH GMBH
Velabs Therapeutics GmbH
Representatives
Michael J. Leonard Fox Rothschild LLP
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Antibodies and the chemical modifications and conjugates thereof for medical research purposes and medical laboratory tests for medical research purposes; Immunoglobulins for medical research use; Structural proteins in the nature of proteins in raw material form and protein arrays for medical research purposes
Class 5
Antibodies and the chemical modifications and conjugates thereof for medical diagnosis and treatment purposes and medical laboratory tests for medical diagnosis and treatment purposes; Immunoglobulins for medical use for the treatment and prevention of disease; Vaccines; Structural proteins in the nature of proteins in raw material form and protein arrays for medical diagnosis and treatment purposes; Veterinary preparationsanti-cancer medicationanti-inflammatory medicationanti-pain medication in creampowdertablet and injectable form; Medical preparationsdiagnostic preparationstherapeutic preparations for medical use in the nature of anti-cancer medicationanti-inflammatory medicationanti-pain medication in creampowdertablet and injectable form; Pharmaceutical preparationsanti-cancer preparationsanti-inflammatory preparationsanti-pain preparationsmetabolic preparations for treating diabetes and obesity in creampowdertabletinjectable form
Class 9
Opto-electronic apparatus and instruments and downloadable and recorded computer software and microfluid chips for conducting antibodypeptide or high-throughput active agent search with small inorganic or organic molecules for scientific research purposes
Class 10
Medical opto-electronic apparatus and instruments for conducting antibodypeptide or high-throughput active agent search with small inorganic or organic molecules for medical diagnosis and treatment purposes
Class 42
Scientific research conducted using high-throughput active agent search and bioinformatics methods; Drug discovery services; Research and testing services in the field of antibody active agent search services for scientific research purposes; Researchtestingdevelopment services in the field of antibody modification and conjugate services for scientific research purposes; Research and testing services in the field of vaccine search services for scientific research purposes
Class 44
Medical services; Medical diagnosis testsmonitoring and reporting and medical screening services in the nature of medical active agent search services; Medical screening services in the nature of medical combing and medical active agent search of antibodies originating from patients; Personal medical information services
Publications
History of USPTO decisions and trademark events.
43 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/13/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/13/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/13/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/13/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/13/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/23/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
01/23/2024
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
12/14/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/14/2023
IUCN
NOTICE OF ALLOWANCE CANCELLED
11/15/2023
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
11/15/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/14/2023
TMBN
TTAB RELEASE CASE TO TRADEMARKS
10/02/2023
OP.T
OPPOSITION TERMINATED NO. 999999
10/02/2023
OP.D
OPPOSITION DISMISSED NO. 999999
10/02/2023
OP.I
OPPOSITION INSTITUTED NO. 999999
08/21/2023
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
03/23/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/21/2023
PUBO
PUBLISHED FOR OPPOSITION
02/21/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/01/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/17/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
01/17/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/17/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
01/17/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/17/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/28/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/27/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/27/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/03/2022
GNRT
NON-FINAL ACTION E-MAILED
10/03/2022
CNRT
NON-FINAL ACTION WRITTEN
10/03/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/25/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/25/2022
ALIE
ASSIGNED TO LIE
08/25/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/29/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/02/2022
GNRT
NON-FINAL ACTION E-MAILED
04/02/2022
CNRT
NON-FINAL ACTION WRITTEN
04/02/2022
DOCK
ASSIGNED TO EXAMINER
03/11/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/05/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/21/2021
NWAP
NEW APPLICATION ENTERED
06/24/2021
Continuous trademark protection
Get notified about every new filing that threatens VERAXA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.